Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Stanford Health Care

Treatment for Familial Dilated Cardiomyopathy

Treatment Options

Patients with familial dilated cardiomyopathy are treated with the same medications that are used to treat other forms of dilated cardiomyopathy and heart failure. Treatment of patients with dilated cardiomyopathy is personalized and depends on both symptoms and clinical findings.

Patients who are asymptomatic may take medications called ACE inhibitors and/or beta-blockers to prevent or halt progression of disease. Patients who are symptomatic are treated with a combination of medications and/or procedures to reduce symptoms and improve life expectancy.

Family members who are at risk for disease may be treated or watched closely over time for manifestations of disease.

ADDITIONAL TREATMENT OPTIONS

Pacemaker

Implantable Cardioverter-Defibrillator (ICD)

Left Ventricular Assist Device

Heart Transplant

Condition Spotlight

Stanford Hospital & Clinics: Dilated Cardiomyopathy Explained Watch Video

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Open Trials Closed Trials